Inflammation in prostate carcinogenesis (original) (raw)

• Jemal, A. et al. Cancer statistics, 2005. CA Cancer J. Clin. 55, 10–30 (2005).
  Article PubMed Google Scholar
• Ames, B. N., Gold, L. S. & Willett, W. C. The causes and prevention of cancer. Proc. Natl Acad. Sci. USA 92, 5258–5265 (1995). This paper describes the main environmental causes of cancer and the molecular mechanisms by which they function.
  Article CAS PubMed PubMed Central Google Scholar
• Coussens, L. M. & Werb, Z. Inflammation and cancer. Nature 420, 860–867 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• ACS. Cancer Facts and FIGS 2005. American Cancer Society, 1–64 (2005).
• De Marzo, A. M. et al. Pathological and molecular mechanisms of prostate carcinogenesis: implications for diagnosis, detection, prevention, and treatment. J. Cell Biochem. 91, 459–477 (2004).
  Article CAS PubMed Google Scholar
• Nelson, W. G., De Marzo, A. M. & Isaacs, W. B. Prostate cancer. N. Engl. J. Med. 349, 366–381 (2003).
  Article CAS PubMed Google Scholar
• Platz, E. A. & De Marzo, A. M. Epidemiology of inflammation and prostate cancer. J. Urol. 171, S36–S40 (2004).
  Article PubMed Google Scholar
• Gonzalgo, M. L. & Isaacs, W. B. Molecular pathways to prostate cancer. J. Urol. 170, 2444–2452 (2003).
  Article CAS PubMed Google Scholar
• Shand, R. L. & Gelmann, E. P. Molecular biology of prostate-cancer pathogenesis. Curr. Opin. Urol. 16, 123–131 (2006).
  Article PubMed Google Scholar
• Pihan, G. A., Wallace, J., Zhou, Y. & Doxsey, S. J. Centrosome abnormalities and chromosome instability occur together in pre-invasive carcinomas. Cancer Res. 63, 1398–1404 (2003).
  CAS PubMed Google Scholar
• Meeker, A. K. Telomeres and telomerase in prostatic intraepithelial neoplasia and prostate cancer biology. Urol. Oncol. 24, 122–130 (2006).
  Article CAS PubMed Google Scholar
• Bostwick, D. G. in Urologic Surgical Pathology (eds Bostwick, D. G. & Eble, J. N.) 423–456 (Mosby, St. Louis, 1997).
  Google Scholar
• Hsing, A. W., Tsao, L. & Devesa, S. S. International trends and patterns of prostate cancer incidence and mortality. Int. J. Cancer 85, 60–67 (2000).
  Article CAS PubMed Google Scholar
• Peto, J. Cancer epidemiology in the last century and the next decade. Nature 411, 390–395 (2001).
  Article CAS PubMed Google Scholar
• McNeal, J. E., Redwine, E. A., Freiha, F. S. & Stamey, T. A. Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am. J. Surg. Pathol. 12, 897–906 (1988).
  Article CAS PubMed Google Scholar
• Franks, L. M. Atrophy and hyperplasia in the prostate proper. J. Pathol. Bacteriol. 68, 617–621 (1954).
  Article CAS PubMed Google Scholar
• McNeal, J. E. in Histology for Pathologists (ed. Sternberg, S. S.) 997–1017 (Lippincott-Raven, Philadelphia, 1997). This book chapter describes in detail the now well established zonal anatomy of the prostate.
  Google Scholar
• De Marzo, A. M., Marchi, V. L., Epstein, J. I. & Nelson, W. G. Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am. J. Pathol. 155, 1985–1992 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Rich, A. R. On the frequency of occurrence of occult carcinoma of the prostate. J. Urol. 33, 215–223 (1934).
  Article Google Scholar
• McNeal, J. E. Normal histology of the prostate. Am. J. Surg. Pathol. 12, 619–633 (1988).
  Article CAS PubMed Google Scholar
• Feneley, M. R., Young, M. P., Chinyama, C., Kirby, R. S. & Parkinson, M. C. Ki-67 expression in early prostate cancer and associated pathological lesions. J. Clin. Pathol. 49, 741–748 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Ruska, K. M., Sauvageot, J. & Epstein, J. I. Histology and cellular kinetics of prostatic atrophy. Am. J. Surg. Pathol. 22, 1073–1077 (1998).
  Article CAS PubMed Google Scholar
• van Leenders, G. J. et al. Intermediate cells in human prostate epithelium are enriched in proliferative inflammatory atrophy. Am. J. Pathol. 162, 1529–1537 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Montironi, R., Mazzucchelli, R. & Scarpelli, M. Precancerous lesions and conditions of the prostate: from morphological and biological characterization to chemoprevention. Ann. NY Acad. Sci. 963, 169–184 (2002).
  Article PubMed Google Scholar
• Nakayama, M. et al. Hypermethylation of the human GSTP1 CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate: a detailed study using Laser-Capture Microdissection. Am. J. Pathol. 163, 923–933 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Putzi, M. J. & De Marzo, A. M. Morphologic transitions between proliferative inflammatory atrophy and high-grade prostatic intraepithelial neoplasia. Urology 56, 828–832 (2000).
  Article CAS PubMed Google Scholar
• Bethel, C. R. et al. Decreased NKX3. 1 protein expression in focal prostatic atrophy, prostatic intraepithelial neoplasia and adenocarcinoma: association with Gleason score and chromosome 8p deletion. Cancer Res. 66, 10683–10690 (2006).
  Article CAS PubMed Google Scholar
• Abate-Shen, C. & Shen, M. M. Mouse models of prostate carcinogenesis. Trends Genet. 18, S1–S5 (2002).
  Article CAS PubMed Google Scholar
• Pelouze, P. S. Gonorrhea in the male and female: a book for practitioners (W. B. Saunders Company, Philadelphia, 1935).
  Google Scholar
• Poletti, F. et al. Isolation of Chlamydia trachomatis from the prostatic cells in patients affected by nonacute abacterial prostatitis. J. Urol. 134, 691–693 (1985).
  Article CAS PubMed Google Scholar
• Gardner, W. A. Jr, Culberson, D. E. & Bennett, B. D. Trichomonas vaginalis in the prostate gland. Arch. Pathol. Lab. Med. 110, 430–432 (1986).
  PubMed Google Scholar
• Thomson, L. Syphilis of the prostate. Am. J. Syphilis 4, 323–341 (1920).
  Google Scholar
• Cohen, R. J., Shannon, B. A., McNeal, J. E., Shannon, T. & Garrett, K. L. Propionibacterium acnes associated with inflammation in radical prostatectomy specimens: a possible link to cancer evolution? J. Urol. 173, 1969–1974 (2005).
  Article PubMed Google Scholar
• Bushman, W. in Prostatic Diseases (ed. Lepor, H.) 550–557 (W. B. Saunders Company, Philadelphia, 2000).
  Google Scholar
• Handsfield, H. H., Lipman, T. O., Harnisch, J. P., Tronca, E. & Holmes, K. K. Asymptomatic gonorrhea in men. Diagnosis, natural course, prevalence and significance. N. Engl. J. Med. 290, 117–123 (1974).
  Article CAS PubMed Google Scholar
• Strickler, H. D. & Goedert, J. J. Sexual behavior and evidence for an infectious cause of prostate cancer. Epidemiol Rev. 23, 144–151 (2001).
  Article CAS PubMed Google Scholar
• Zambrano, A., Kalantari, M., Simoneau, A., Jensen, J. L. & Villarreal, L. P. Detection of human polyomaviruses and papillomaviruses in prostatic tissue reveals the prostate as a habitat for multiple viral infections. Prostate 53, 263–276 (2002).
  Article CAS PubMed Google Scholar
• Samanta, M., Harkins, L., Klemm, K., Britt, W. J. & Cobbs, C. S. High prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carcinoma. J. Urol. 170, 998–1002 (2003).
  Article PubMed Google Scholar
• Riley, D. E., Berger, R. E., Miner, D. C. & Krieger, J. N. Diverse and related 16S rRNA-encoding DNA sequences in prostate tissues of men with chronic prostatitis. J. Clin. Microbiol. 36, 1646–1652 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Urisman, A. et al. Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog. 2, e25 (2006). This study used a new gene chip containing all known viral nucleic acids to identify a new virus in the prostate. Only men with inherited inactive RNASEL alleles were at a high risk of harbouring the virus.
  Article PubMed PubMed Central CAS Google Scholar
• Platz, E. A. et al. Nonsteroidal anti-inflammatory drugs and risk of prostate cancer in the Baltimore Longitudinal Study of Aging. Cancer Epidemiol. Biomarkers Prev. 14, 390–396 (2005).
  Article CAS PubMed Google Scholar
• Mahmud, S., Franco, E. & Aprikian, A. Prostate cancer and use of nonsteroidal anti-inflammatory drugs: systematic review and meta-analysis. Br. J. Cancer 90, 93–99 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Chan, J. M., Feraco, A., Shuman, M. & Hernandez-Diaz, S. The epidemiology of prostate cancer — with a focus on nonsteroidal anti-inflammatory drugs. Hematol. Oncol. Clin. North Am. 20, 797–809 (2006).
  Article PubMed Google Scholar
• Jacobs, E. J. et al. A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence. J. Natl Cancer Inst. 97, 975–980 (2005).
  Article PubMed Google Scholar
• Dennis, L. K., Lynch, C. F. & Torner, J. C. Epidemiologic association between prostatitis and prostate cancer. Urology 60, 78–83 (2002).
  Article PubMed Google Scholar
• Sarma, A. V. et al. Sexual behavior, sexually transmitted diseases and prostatitis: the risk of prostate cancer in black men. J. Urol. 176, 1108–1113 (2006).
  Article PubMed Google Scholar
• Sutcliffe, S. et al. Gonorrhea, syphilis, clinical prostatitis, and the risk of prostate cancer. Cancer Epidemiol. Biomarkers Prev. 15, 2160–2166 (2006).
  Article PubMed Google Scholar
• Nickel, J. C. et al. Consensus development of a histopathological classification system for chronic prostatic inflammation. BJU Int. 87, 797–805 (2001).
  Article CAS PubMed Google Scholar
• Feigl, P. et al. Design of the Prostate Cancer Prevention Trial (PCPT). Control Clin. Trials 16, 150–163 (1995).
  Article CAS PubMed Google Scholar
• Kirby, R. S., Lowe, D., Bultitude, M. I. & Shuttleworth, K. E. Intra-prostatic urinary reflux: an aetiological factor in abacterial prostatitis. Br. J. Urol. 54, 729–731 (1982).
  Article CAS PubMed Google Scholar
• Persson, B. E. & Ronquist, G. Evidence for a mechanistic association between nonbacterial prostatitis and levels of urate and creatinine in expressed prostatic secretion. J. Urol. 155, 958–960 (1996).
  Article CAS PubMed Google Scholar
• Martinon, F., Petrilli, V., Mayor, A., Tardivel, A. & Tschopp, J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440, 237–241 (2006). This paper presented genetic evidence that uric acid crystals can activate the inflammasome, and therefore produce a potent inflammatory response.
  Article CAS PubMed Google Scholar
• Drachenberg, C. B. & Papadimitriou, J. C. Prostatic corpora amylacea and crystalloids: similarities and differences on ultrastructural and histochemical studies. J. Submicrosc. Cytol. Pathol. 28, 141–150 (1996).
  CAS PubMed Google Scholar
• Gardner, W. A. & Bennett, B. D. in Pathology and pathobiology of the urinary bladder and prostate (eds Weinstein, R. S. & Garnder, W. A.) 129–148 (Williams and Wilkens, Baltimore, 1992).
  Google Scholar
• Meares, E. M. Jr. Infection stones of prostate gland. Laboratory diagnosis and clinical management. Urology 4, 560–566 (1974).
  Article PubMed Google Scholar
• Joachim, H. La lithiase prostatique peut-elle etre consideree comme un facteur cancerogene? Urologia (Treviso) 28, 1–11 (1961).
  Google Scholar
• Cristol, D. S. & Emmett, J. L. Incidence of coincident prostatic calculi, prostatic hyperplasia and carcinoma of prostate gland. JAMA 124, 646–652 (1944).
  Article Google Scholar
• Sondergaard, G., Vetner, M. & Christensen, P. O. Prostatic calculi. Acta Pathol. Microbiol. Immunol. Scand. [A] 95, 141–145 (1987).
  CAS Google Scholar
• Isaacs, J. T. Prostatic structure and function in relation to the etiology of prostatic cancer. Prostate 4, 351–366 (1983).
  Article CAS PubMed Google Scholar
• Leitzmann, M. F., Platz, E. A., Stampfer, M. J., Willett, W. C. & Giovannucci, E. Ejaculation frequency and subsequent risk of prostate cancer. JAMA 291, 1578–1586 (2004). This paper presents evidence that high ejaculation frequency, especially in young men, is related to reduced prostate cancer incidence, and therefore suggests that the 'flushing' of the prostate of harmful chemicals or infectious agents might reduce prostate cancer risk.
  Article CAS PubMed Google Scholar
• Chen, X., Zhao, J., Salim, S. & Garcia, F. U. Intraprostatic spermatozoa: zonal distribution and association with atrophy. Hum. Pathol. 37, 345–351 (2006).
  Article PubMed Google Scholar
• Giovannucci, E. et al. A prospective study of dietary fat and risk of prostate cancer. J. Natl Cancer Inst. 85, 1571–1579 (1993).
  Article CAS PubMed Google Scholar
• Norrish, A. E. et al. Heterocyclic amine content of cooked meat and risk of prostate cancer. J. Natl Cancer Inst. 91, 2038–2044 (1999).
  Article CAS PubMed Google Scholar
• Michaud, D. S. et al. A prospective study on intake of animal products and risk of prostate cancer. Cancer Causes Control 12, 557–567 (2001).
  Article CAS PubMed Google Scholar
• Sugimura, T., Wakabayashi, K., Nakagama, H. & Nagao, M. Heterocyclic amines: Mutagens/carcinogens produced during cooking of meat and fish. Cancer Sci. 95, 290–299 (2004). This paper reviews the intriguing discovery of highly mutagenic and carcinogenic compounds formed during the high-temperature cooking of meats.
  Article CAS PubMed Google Scholar
• Knize, M. G. & Felton, J. S. Formation and human risk of carcinogenic heterocyclic amines formed from natural precursors in meat. Nutr. Rev. 63, 158–165 (2005). This paper reviews the discovery and significance of PhIP as the most abundant of the heterocyclic amines produced by high-temperature cooking of meats.
  Article PubMed Google Scholar
• Inaguma, S. et al. High susceptibility of the ACI and spontaneously hypertensive rat (SHR) strains to 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine (PhIP) prostate carcinogenesis. Cancer Sc.i 94, 974–979 (2003).
  Article CAS Google Scholar
• Nakai, Y., Nelson, W. G. & De Marzo, A. M. The dietary charred meat carcinogen 2-amino-1-methyl-6-phenylimidazo[4, 5_b_]pyridine (PhIP) acts as both an initiator and tumor promoter in the rat ventral prostate. Cancer Res. 67, 1378–1384 (2007).
  Article CAS PubMed Google Scholar
• Borowsky, A. D. et al. Inflammation and atrophy precede prostatic neoplasia in a PhIP-induced rat model. Neoplasia 8, 708–715 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Malaviya, R., Ikeda, T., Ross, E. & Abraham, S. N. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α. Nature 381, 77–80 (1996).
  Article CAS PubMed Google Scholar
• Choo-Kang, B. S. et al. TNF-blocking therapies: an alternative mode of action? Trends Immunol. 26, 518–522 (2005).
  Article CAS PubMed Google Scholar
• Araki, Y., Andoh, A., Fujiyama, Y. & Bamba, T. Development of dextran sulphate sodium-induced experimental colitis is suppressed in genetically mast cell-deficient Ws/Ws rats. Clin. Exp. Immunol. 119, 264–269 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Coffey, D. S. Similarities of prostate and breast cancer: Evolution, diet, and estrogens. Urology 57, 31–38 (2001).
  Article CAS PubMed Google Scholar
• Harkonen, P. L. & Makela, S. I. Role of estrogens in development of prostate cancer. J. Steroid Biochem. Mol. Biol. 92, 297–305 (2004).
  Article CAS PubMed Google Scholar
• Gilleran, J. P. et al. The role of prolactin in the prostatic inflammatory response to neonatal estrogen. Endocrinology 144, 2046–2054 (2003).
  Article CAS PubMed Google Scholar
• Huang, L., Pu, Y., Alam, S., Birch, L. & Prins, G. S. Estrogenic regulation of signaling pathways and homeobox genes during rat prostate development. J. Androl. 25, 330–337 (2004).
  Article CAS PubMed Google Scholar
• Naslund, M. J., Strandberg, J. D. & Coffey, D. S. The role of androgens and estrogens in the pathogenesis of experimental nonbacterial prostatitis. J. Urol. 140, 1049–1053 (1988).
  Article CAS PubMed Google Scholar
• Huang, L., Pu, Y., Alam, S., Birch, L. & Prins, G. S. The role of Fgf10 signaling in branching morphogenesis and gene expression of the rat prostate gland: lobe-specific suppression by neonatal estrogens. Dev. Biol. 278, 396–414 (2005).
  Article CAS PubMed Google Scholar
• Prins, G. S. et al. Estrogen imprinting of the developing prostate gland is mediated through stromal estrogen receptor a: studies with aERKO and bERKO mice. Cancer Res. 61, 6089–6097 (2001).
  CAS PubMed Google Scholar
• Ponniah, S., Arah, I. & Alexander, R. B. PSA is a candidate self-antigen in autoimmune chronic prostatitis/chronic pelvic pain syndrome. Prostate 44, 49–54 (2000).
  Article CAS PubMed Google Scholar
• Theyer, G. et al. Phenotypic characterization of infiltrating leukocytes in benign prostatic hyperplasia. Lab. Invest. 66, 96–107 (1992).
  CAS PubMed Google Scholar
• Bostwick, D. G., de la Roza, G., Dundore, P., Corica, F. A. & Iczkowski, K. A. Intraepithelial and stromal lymphocytes in the normal human prostate. Prostate 55, 187–193 (2003).
  Article PubMed Google Scholar
• De Marzo, A. M. in Prostate Cancer: Biology, Genetics and the New Therapeutics (eds Chung, L. W. K., Isaacs, W. B. & Simons, J. W.) (Humana Press, Totawa, NJ, in the press).
• Steiner, G. E. et al. The picture of the prostatic lymphokine network is becoming increasingly complex. Rev. Urol. 4, 171–177 (2002).
  PubMed PubMed Central Google Scholar
• Steiner, G. E. et al. Expression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate. Prostate 56, 171–182 (2003).
  Article CAS PubMed Google Scholar
• Steiner, G. E. et al. Cytokine expression pattern in benign prostatic hyperplasia infiltrating T cells and impact of lymphocytic infiltration on cytokine mRNA profile in prostatic tissue. Lab. Invest. 83, 1131–1146 (2003).
  Article CAS PubMed Google Scholar
• Erdman, S. E. et al. CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice. Am. J. Pathol. 162, 691–702 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Miller, A. M. et al. CD4+CD25high T cells are enriched in the tumor and peripheral blood of prostate cancer patients. J. Immunol. 177, 7398–7405 (2006).
  Article CAS PubMed Google Scholar
• Weaver, C. T., Harrington, L. E., Mangan, P. R., Gavrieli, M. & Murphy, K. M. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24, 677–688 (2006). This paper reviews the discovery and characterization of a new class of T cells responsible for some forms of autoimmunity and perhaps cancer formation in a number of systems.
  Article CAS PubMed Google Scholar
• Langowski, J. L. et al. IL-23 promotes tumour incidence and growth. Nature 442, 461–465 (2006). This paper shows the requirement for IL23 in carcinogen-induced skin cancers in animals, and that it functions by inhibiting tumour immune surveillance.
  Article CAS PubMed Google Scholar
• Schaid, D. J. The complex genetic epidemiology of prostate cancer. Hum. Mol. Genet. 13 Spec No 1, R103–R121 (2004).
  Article CAS PubMed Google Scholar
• Smith, J. R. et al. Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science 274, 1371–1374 (1996). This is the first report in which, using a genome-wide scanning approach, a major prostate cancer-susceptibility gene was identified.
  Article CAS PubMed Google Scholar
• Carpten, J. et al. Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nature Genet. 30, 181–184 (2002).
  Article CAS PubMed Google Scholar
• Silverman, R. H. Implications for RNase L in prostate cancer biology. Biochemistry 42, 1805–1812 (2003).
  Article CAS PubMed Google Scholar
• Hassel, B. A., Zhou, A., Sotomayor, C., Maran, A. & Silverman, R. H. A dominant negative mutant of 2–5A-dependent RNase suppresses antiproliferative and antiviral effects of interferon. EMBO J. 12, 3297–3304 (1993).
  Article CAS PubMed PubMed Central Google Scholar
• Wiklund, F. et al. Genetic analysis of the RNASEL gene in hereditary, familial, and sporadic prostate cancer. Clin. Cancer Res. 10, 7150–7156 (2004).
  Article CAS PubMed Google Scholar
• Maier, C. et al. Mutation screening and association study of RNASEL as a prostate cancer susceptibility gene. Br. J. Cancer 92, 1159–1164 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Rennert, H. et al. Association of susceptibility alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with prostate cancer severity in European American and African American men. Cancer Epidemiol. Biomarkers Prev. 14, 949–957 (2005).
  Article CAS PubMed Google Scholar
• Kotar, K., Hamel, N., Thiffault, I. & Foulkes, W. D. The RNASEL 471delAAAG allele and prostate cancer in Ashkenazi Jewish men. J. Med. Genet. 40, e22 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Malathi, K. et al. A transcriptional signaling pathway in the IFN system mediated by 2'-5'-oligoadenylate activation of RNase L. Proc. Natl Acad. Sci. USA 102, 14533–14538 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Xu, J. et al. Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk. Nature Genet. 32, 321–325 (2002).
  Article CAS PubMed Google Scholar
• Gough, P. J., Greaves, D. R. & Gordon, S. A naturally occurring isoform of the human macrophage scavenger receptor (SR-A) gene generated by alternative splicing blocks modified LDL uptake. J. Lipid. Res. 39, 531–543 (1998).
  Article CAS PubMed Google Scholar
• Peiser, L. et al. The class A macrophage scavenger receptor is a major pattern recognition receptor for Neisseria meningitidis which is independent of lipopolysaccharide and not required for secretory responses. Infect. Immun. 70, 5346–5354 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Ozeki, Y. et al. Macrophage scavenger receptor down-regulates mycobacterial cord factor-induced proinflammatory cytokine production by alveolar and hepatic macrophages. Microb. Pathog. 40, 171–176 (2006).
  Article CAS PubMed Google Scholar
• Cotena, A., Gordon, S. & Platt, N. The class A macrophage scavenger receptor attenuates CXC chemokine production and the early infiltration of neutrophils in sterile peritonitis. J. Immunol. 173, 6427–6432 (2004).
  Article CAS PubMed Google Scholar
• Xu, J. et al. Common sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk. Am. J. Hum. Genet. 72, 208–212 (2003).
  Article CAS PubMed Google Scholar
• Miller, D. C. et al. Germ-line mutations of the macrophage scavenger receptor 1 gene: association with prostate cancer risk in African-American men. Cancer Res. 63, 3486–3489 (2003).
  CAS PubMed Google Scholar
• Wang, L. et al. No association of germline alteration of MSR1 with prostate cancer risk. Nature Genet. 35, 128–129 (2003).
  Article CAS PubMed Google Scholar
• Seppala, E. H. et al. Germ-line alterations in MSR1 gene and prostate cancer risk. Clin. Cancer Res. 9, 5252–5256 (2003).
  PubMed Google Scholar
• Hope, Q. et al. Macrophage scavenger receptor 1 999C>T (R293X) mutation and risk of prostate cancer. Cancer Epidemiol. Biomarkers Prev. 14, 397–402 (2005).
  Article CAS PubMed Google Scholar
• Lindmark, F. et al. Analysis of the macrophage scavenger receptor 1 gene in Swedish hereditary and sporadic prostate cancer. Prostate 59, 132–140 (2004).
  Article CAS PubMed Google Scholar
• Sun, J. et al. Meta-analysis of association of rare mutations and common sequence variants in the MSR1 gene and prostate cancer risk. Prostate 66, 728–737 (2006).
  Article CAS PubMed Google Scholar
• Janeway, C. A. Jr. & Medzhitov, R. Innate immune recognition. Annu. Rev. Immunol. 20, 197–216 (2002).
  Article CAS PubMed Google Scholar
• Zheng, S. L. et al. Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study. Cancer Res. 64, 2918–2922 (2004).
  Article CAS PubMed Google Scholar
• Sun, J. et al. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk. J. Natl Cancer Inst. 97, 525–532 (2005).
  Article CAS PubMed Google Scholar
• Poltorak, A. et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085–2088 (1998).
  Article CAS PubMed Google Scholar
• Ohashi, K., Burkart, V., Flohe, S. & Kolb, H. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J. Immunol. 164, 558–561 (2000).
  Article CAS PubMed Google Scholar
• Chen, Y. C. et al. Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer. Cancer Res. 65, 11771–11778 (2005).
  Article CAS PubMed Google Scholar
• Chuang, T. & Ulevitch, R. J. Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells. Biochim. Biophys. Acta 1518, 157–161 (2001).
  Article CAS PubMed Google Scholar
• Takeuchi, O. et al. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J. Immunol. 169, 10–14 (2002).
  Article CAS PubMed Google Scholar
• Yamamoto, M., Takeda, K. & Akira, S. TIR domain-containing adaptors define the specificity of TLR signaling. Mol. Immunol. 40, 861–868 (2004).
  Article CAS PubMed Google Scholar
• Takeuchi, O. et al. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int. Immunol. 13, 933–940 (2001).
  Article CAS PubMed Google Scholar
• Hajjar, A. M. et al. Cutting edge: functional interactions between toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol-soluble modulin. J. Immunol. 166, 15–19 (2001).
  Article CAS PubMed Google Scholar
• Lindmark, F. et al. H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer. J. Natl Cancer Inst. 96, 1248–1254 (2004).
  Article CAS PubMed Google Scholar
• Lindmark, F. et al. Interleukin-1 receptor antagonist haplotype associated with prostate cancer risk. Br. J. Cancer 93, 493–497 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• McCarron, S. L. et al. Influence of cytokine gene polymorphisms on the development of prostate cancer. Cancer Res. 62, 3369–3372 (2002).
  CAS PubMed Google Scholar
• Michaud, D. S. et al. Genetic polymorphisms of interleukin-1B (IL-1B), IL-6, IL-8, and IL-10 and risk of prostate cancer. Cancer Res. 66, 4525–4530 (2006).
  Article CAS PubMed Google Scholar
• Zheng, S. L. et al. A comprehensive association study for genes in inflammation pathway provides support for their roles in prostate cancer risk in the CAPS study. Prostate 66, 1556–1564 (2006).
  Article CAS PubMed Google Scholar
• Kasper, S. Survey of genetically engineered mouse models for prostate cancer: analyzing the molecular basis of prostate cancer development, progression, and metastasis. J. Cell Biochem. 94, 279–297 (2005).
  Article CAS PubMed Google Scholar
• Freedman, M. L. et al. Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. Proc. Natl Acad. Sci. USA 103, 14068–14073 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Amundadottir, L. T. et al. A common variant associated with prostate cancer in European and African populations. Nature Genet. 38, 652–658 (2006).
  Article CAS PubMed Google Scholar
• Groopman, J. D. & Kensler, T. W. Role of metabolism and viruses in aflatoxin-induced liver cancer. Toxicol. Appl. Pharmacol. 206, 131–137 (2005).
  Article CAS PubMed Google Scholar
• Condeelis, J. & Pollard, J. W. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124, 263–266 (2006).
  Article CAS PubMed Google Scholar
• Lewis, C. E. & Pollard, J. W. Distinct role of macrophages in different tumor microenvironments. Cancer Res. 66, 605–612 (2006).
  Article CAS PubMed Google Scholar
• de Visser, K. E., Eichten, A. & Coussens, L. M. Paradoxical roles of the immune system during cancer development. Nature Rev. Cancer 6, 24–37 (2006).
  Article CAS Google Scholar
• Chisari, F. V. Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B. Am. J. Pathol. 156, 1117–1132 (2000). This paper reviews the key discovery that liver cancer can be induced simply by the transfer of activated T cells that recognize virally encoded antigens.
  Article CAS PubMed PubMed Central Google Scholar
• Neill, M. G. & Fleshner, N. E. An update on chemoprevention strategies in prostate cancer for 2006. Curr. Opin. Urol. 16, 132–137 (2006).
  Article PubMed Google Scholar
• Coussens, L. M., Tinkle, C. L., Hanahan, D. & Werb, Z. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103, 481–90 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Dranoff, G. Cytokines in cancer pathogenesis and cancer therapy. Nature Rev. Cancer 4, 11–22 (2004).
  Article CAS Google Scholar
• Tsujimoto, Y., Takayama, H., Nonomura, N., Okuyama, A. & Aozasa, K. Postatrophic hyperplasia of the prostate in Japan: histologic and immunohistochemical features and p53 gene mutation analysis. Prostate 52, 279–287 (2002).
  Article CAS PubMed Google Scholar
• Tsujimoto, Y. et al. In situ shortening of CAG repeat length within the androgen receptor gene in prostatic cancer and its possible precursors. Prostate 58, 283–290 (2004).
  Article CAS PubMed Google Scholar
• Shah, R., Mucci, N. R., Amin, A., Macoska, J. A. & Rubin, M. A. Postatrophic hyperplasia of the prostate gland: neoplastic precursor or innocent bystander? Am. J. Pathol. 158, 1767–1773 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Yildiz-Sezer, S. et al. Assessment of aberrations on chromosome 8 in prostatic atrophy. BJU Int. 98, 184–188 (2006).
  Article CAS PubMed Google Scholar
• Macoska, J. A., Trybus, T. M. & Wojno, K. J. 8p22 loss concurrent with 8c gain is associated with poor outcome in prostate cancer. Urology 55, 776–782 (2000).
  Article CAS PubMed Google Scholar
• Guo, Y. P., Sklar, G. N., Borkowski, A. & Kyprianou, N. Loss of the cyclin-dependent kinase inhibitor P27(Kip1) protein in human prostate cancer correlates with tumor grade. Clin. Cancer Res. 3, 2269–2274 (1997).
  CAS PubMed Google Scholar
• De Marzo, A. M., Meeker, A. K., Epstein, J. I. & Coffey, D. S. Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells. Am. J. Pathol. 153, 911–919 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Yang, R. M. et al. Low p27 expression predicts poor disease-free survival in patients with prostate cancer. J. Urol. 159, 941–945 (1998).
  Article CAS PubMed Google Scholar
• Denicourt, C. & Dowdy, S. F. Cip/Kip proteins: more than just CDKs inhibitors. Genes Dev. 18, 851–855 (2004).
  Article CAS PubMed Google Scholar
• Vivanco, I. & Sawyers, C. L. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nature Rev. Cancer 2, 489–501 (2002).
  Article CAS Google Scholar
• Shen, M. M. & Abate-Shen, C. Roles of the Nkx3.1 homeobox gene in prostate organogenesis and carcinogenesis. Dev. Dyn. 228, 767–778 (2003).
  Article CAS PubMed Google Scholar
• Ouyang, X., DeWeese, T. L., Nelson, W. G. & Abate-Shen, C. Loss-of-function of Nkx3.1 promotes increased oxidative damage in prostate carcinogenesis. Cancer Res. 65, 6773–6779 (2005).
  Article CAS PubMed Google Scholar
• Parsons, J. K. et al. GSTA1 expression in normal, preneoplastic, and neoplastic human prostate tissue. Prostate 49, 30–37 (2001).
  Article CAS PubMed Google Scholar
• Zha, S. et al. Cyclooxygenase-2 is up-regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinoma. Cancer Res. 61, 8617–8623 (2001).
  CAS PubMed Google Scholar
• Knudsen, B. S. et al. Regulation of hepatocyte activator inhibitor-1 expression by androgen and oncogenic transformation in the prostate. Am. J. Pathol. 167, 255–266 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Dennis, L. K. & Dawson, D. V. Meta-analysis of measures of sexual activity and prostate cancer. Epidemiology 13, 72–79 (2002).
  Article PubMed Google Scholar
• Taylor, M. L., Mainous, A. G., 3rd & Wells, B. J. Prostate cancer and sexually transmitted diseases: a meta-analysis. Fam. Med. 37, 506–512 (2005).
  PubMed Google Scholar
• Sutcliffe, S. et al. Plasma antibodies against Trichomonas vaginalis and subsequent risk of prostate cancer. Cancer Epidemiol. Biomarkers Prev. 15, 939–945 (2006). This is the first study linking objective evidence of exposure to Trichomonas vaginalis with prostate cancer risk.
  Article CAS PubMed Google Scholar
• Sutcliffe, S. et al. Sexually transmitted infections and prostatic inflammation/cell damage as measured by serum prostate specific antigen concentration. J. Urol. 175, 1937–1942 (2006).
  Article PubMed Google Scholar